Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma

Detalles Bibliográficos
Autores principales: Costacurta, Matteo, Vervoort, Stephin J, Hogg, Simon J, Martin, Benjamin P, Johnstone, Ricky W, Shortt, Jake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252923/
https://www.ncbi.nlm.nih.gov/pubmed/33375771
http://dx.doi.org/10.3324/haematol.2020.265611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252923/
https://www.ncbi.nlm.nih.gov/pubmed/33375771
http://dx.doi.org/10.3324/haematol.2020.265611

Ejemplares similares